E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/15/2019 in the Prospect News Structured Products Daily.

JPMorgan plans contingent interest autocalls tied to CVS, Walgreens

By Wendy Van Sickle

Columbus, Ohio, Feb. 15 – JPMorgan Chase Financial Co. LLC plans to price autocallable contingent interest notes due Feb. 17, 2022 linked to the least performing of the common stocks of CVS Health Corp. and Walgreens Boots Alliance, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of at least 9.3% if each stock closes at or above its 70% coupon barrier on the review date for that quarter.

The notes will be called at par plus the contingent coupon if each stock closes at or above its initial level on any quarterly review date other than the final one.

The payout at maturity will be par unless either underlying stock finishes below its 70% trigger level, in which case investors will be fully exposed to any losses of the worst performing stock.

The notes are guaranteed by JPMorgan Chase & Co.

J.P. Morgan Securities LLC is the agent.

The notes will price on Feb. 27.

The Cusip number is 48130W2K6.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.